Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Hicks

Showing results (41-50 of 470) with videos related to

Pageof 47
Sort By:
The Oncologist|June 17, 2008
PET for sarcomas other than gastrointestinal stromal tumorsGuy C Toner, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Restaging: should we percist without pattern recognition?Michael S Hofman, Rodney J Hicks
Leukemia & Lymphoma|December 30, 2009
Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphomaMichael S Hofman, Rodney J Hicks
Seminars in Nuclear Medicine|August 25, 2016
Gallium-68 EDTA PET/CT for Renal ImagingMichael S Hofman, Rodney J Hicks
Nature Reviews. Clinical Oncology|November 15, 2012
Is there still a role for SPECT-CT in oncology in the PET-CT era?Rodney J Hicks, Michael S Hofman
Endocrine-Related Cancer|April 13, 2017
Molecular imaging in the investigation of hypoglycaemic syndromes and their managementDavid A Pattison, Rodney J Hicks
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2013
Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?Michael S Hofman, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
THYROPET Study: Is It Biology or Technology That Is the Issue?David A Pattison, Rodney J Hicks
Discovery Medicine|August 1, 2012
Changing paradigms with molecular imaging of neuroendocrine tumorsMichael S Hofman, Rodney J Hicks
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Cancer imaging: quo vadis?Rodney J Hicks, Kenneth A Miles
Pageof 47

Showing results (41-50 of 470) with videos related to

Sort By:
Pageof 47
The Oncologist|June 17, 2008
PET for sarcomas other than gastrointestinal stromal tumorsGuy C Toner, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Restaging: should we percist without pattern recognition?Michael S Hofman, Rodney J Hicks
Leukemia & Lymphoma|December 30, 2009
Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphomaMichael S Hofman, Rodney J Hicks
Seminars in Nuclear Medicine|August 25, 2016
Gallium-68 EDTA PET/CT for Renal ImagingMichael S Hofman, Rodney J Hicks
Nature Reviews. Clinical Oncology|November 15, 2012
Is there still a role for SPECT-CT in oncology in the PET-CT era?Rodney J Hicks, Michael S Hofman
Endocrine-Related Cancer|April 13, 2017
Molecular imaging in the investigation of hypoglycaemic syndromes and their managementDavid A Pattison, Rodney J Hicks
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2013
Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?Michael S Hofman, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
THYROPET Study: Is It Biology or Technology That Is the Issue?David A Pattison, Rodney J Hicks
Discovery Medicine|August 1, 2012
Changing paradigms with molecular imaging of neuroendocrine tumorsMichael S Hofman, Rodney J Hicks
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Cancer imaging: quo vadis?Rodney J Hicks, Kenneth A Miles
Pageof 47